Weakness Mega Study
Contents
Weakness
Weakness

Related

A
1 to 5 Rating
A
Symptoms
A
Factors
A
Outcomes
A
User Variables 1
A
Measurements 28

Tags

Weakness
Weaknes
Weakne

Treatments Causing Weakness

User-reported treatments that exhibited the side effect of Weakness

Treatment Percent of Reports
Zanaflex 34%
Lyrica 41%
Oxycodone 20%
Pregabalin 41%
Valium 29%
Tramadol 24%
Oxycodone (Percocet) 20%
Tramadol (Ultram) 24%
Baclofen 36%
Pregabalin (Lyrica) 41%
Fluoxetine (Prozac) 23%
Duloxetine (Cymbalta) 33%
Diazepam 29%
Copaxone 48%
Paroxetine 31%
Leuprolide 75%
Depo-Provera 69%
Paroxetine (Paxil) 31%
Metformin 21%
Claritin 7%
Sudafed 8%
Loratadine 7%
Pseudoephedrine 8%
Lorazepam (Ativan) 26%
Quetiapine 41%
Testosterone 14%
Ambien 27%
Diazepam (Valium) 29%
Relpax 29%
Zomig 37%
Morphine 42%
Topiramate (Topamax) 32%
Sumatriptan 30%
Eletriptan 29%
Tizanidine 34%
Quetiapine (Seroquel) 41%

Below is the change in Weakness seen after the predictor is higher than average.

Predictors
of
Below is the change in after the listed predictor is higher than average.
Sort by Effect Size
Sort by Confidence
% Change from Baseline*
*
Change from the average seen after the predictor is higher than average.

Weakness Info

Property Value
Variable Name Weakness
Aggregation Method MEAN
Analysis Performed At 2020-10-09
Duration of Action 24 hours
Kurtosis 1.3125
Maximum Allowed Value 5 out of 5
Mean 3.5 out of 5
Median 3 out of 5
Minimum Allowed Value 1 out of 5
Number of Aggregate Predictors 5
Number of Aggregate Outcomes 5
Number of Measurements 28
Number of Measurements (including those generated by tagged, joined, or child variables) 28
Public true
Onset Delay 0 seconds
Standard Deviation 1.2724180205607
Unit 1 to 5 Rating
User Variables 1
Variable Category Symptoms
Variable ID 87823
Variance 1.6190476190476